Cite Filings / NRIX / 0001086364-24-007816
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G/A

Amended Statement of Ownership

Nurix Therapeutics, Inc. · Filed 2024-06-07 · Acc 0001086364-24-007816

Documents 1

  • SC 13G/A Amended Statement of Ownership , us67080m1036_060724.txt

Around this filing

  • 2024-11-07 SC 13G/A Amended Statement of Ownership
  • 2024-06-11 S-3ASR Registration Statement
  • 2024-06-07 SC 13G/A Amended Statement of Ownership
  • 2024-06-05 4 Chief Legal Officer sold 400 shares at $17.00 ($6,801)
  • 2024-06-03 144 Sale of Securities
  • 2024-06-03 4 Chief Legal Officer sold 1,596 shares at $17.01 ($27,153)
  • 2024-02-14 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Perceptive Advisors LLC 4.9%
  2. 2026-11-16 SCHEDULE 13G/A · Deep Track Capital, LP 5.49%
  3. 2026-11-16 SCHEDULE 13G/A · Rubric Capital Management LP 4.55%
  4. 2026-11-16 SCHEDULE 13G/A · Vestal Point Capital, LP 6.4%
  5. 2026-11-16 SCHEDULE 13G/A · T. Rowe Price Associates, Inc. 4.4%
Loading us67080m1036_060724.txt…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…